Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis. Biomark Insights.

Ozenirler S, Sancak B, Coskun U.

Serum and Ascitic Fluid Superoxide Dismutase and Malondialdehyde Levels in Patients with Cirrhosis. Biomark Insights.

2008 Mar 12;3:141-145. PubMed PMID: 19578501; PubMed Central PMCID: PMC2688367.

Related Articles

Serum and ascitic fluid nitrate levels in patients with cirrhosis.

21 October 2020

Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. 

21 October 2020

A case of Sweet’s syndrome developed after the treatment of herpes simplex infection in a metastatic breast cancer patient.

21 October 2020

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

21 October 2020
Back to top button
0312 229 20 55